Academic Journal
Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC
| العنوان: | Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC |
|---|---|
| المؤلفون: | Ou, S.-H. I., Jänne, P.A., Bartlett, C.H., Tang, Y., Kim, D.-W., Otterson, G.A., Crinò, L., Selaru, P., Cohen, D.P., Clark, J.W., Riely, G.J. |
| سنة النشر: | 2014 |
| المجموعة: | Istituto Nazionale di Fisica Nucleare (INFN): Open Access Repository |
| مصطلحات موضوعية: | Oncology, Hematology |
| الوصف: | n/a |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| Relation: | url:https://www.openaccessrepository.it/communities/itmirror; https://www.openaccessrepository.it/record/164632 |
| DOI: | 10.1093/annonc/mdt572 |
| الاتاحة: | https://www.openaccessrepository.it/record/164632 https://doi.org/10.1093/annonc/mdt572 |
| Rights: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.753E1B3A |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/annonc/mdt572 |
|---|